focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,166.00
Bid: 12,132.00
Ask: 12,136.00
Change: -6.00 (-0.05%)
Spread: 4.00 (0.033%)
Open: 12,180.00
High: 12,198.00
Low: 12,076.00
Prev. Close: 12,172.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Jefferies cuts Persimmon; BoA cuts GSK

Mon, 05th Dec 2022 10:00

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

----------

FTSE 100

----------

Bank of America cuts Vodafone price target to 130 (140) pence - 'neutral'

----------

Bank of America cuts BT Group price target to 187 (223) pence - 'buy'

----------

Bank of America cuts GSK to 'underperform' (neutral) - price target 1,450 (1,640) pence

----------

Bank of America raises AstraZeneca price target to 14,500 (12,500) pence - 'buy'

----------

Bernstein cuts Reckitt Benckiser price target to 6,100 (6,400) pence - 'market-perform'

----------

Bernstein cuts Unilever to 'market-perform' (outperform) - price target 3,500 (4,280) pence

----------

RBC raises Compass Group price target to 1,625 (1,575) pence - 'underperform'

----------

JPMorgan raises B&M price target to 555 (414) pence - 'overweight'

----------

JPMorgan raises Sainsbury price target to 206 (161) pence - 'underweight'

----------

JPMorgan raises Tesco price target to 270 (240) pence - 'overweight'

----------

Jefferies raises Barratt Developments price target to 452 (356) pence - 'hold'

----------

Jefferies cuts Persimmon to 'hold' (buy) - price target 1,436 (1485) pence

----------

Jefferies raises Taylor Wimpey price target to 124 (105) pence - 'buy'

----------

Jefferies raises Berkeley Group price target to 4,554 (4,330) pence - 'buy'

----------

Jefferies raises CRH price target to 51.60 (50.30) EUR - 'buy'

----------

Jefferies cuts Spirax-Sarco price target to 9,910 (11,460) pence - 'underperform'

----------

FTSE 250

----------

Bank of America raises Helios Towers price target to 180 (175) pence - 'buy'

----------

Morgan Stanley cuts Hays price target to 145 (146) pence - 'overweight'

----------

Morgan Stanley cuts PageGroup to 'equal-weight' (overweight) - price target 505 (510) pence

----------

UBS raises easyJet price target to 600 (565) pence - 'buy'

----------

Jefferies raises Travis Perkins price target to 931 (811) pence - 'hold'

----------

Jefferies raises Redrow price target to 592 (491) pence - 'buy'

----------

Jefferies raises Crest Nicholson price target to 278 (229) pence - 'buy'

----------

Jefferies raises Vistry price target to 829 (744) pence - 'buy'

----------

Jefferies raises Bellway to 'buy' (hold) - price target 2,458 (1,928) pence

----------

SMALL CAP

----------

Citigroup cuts Gamma Communications price target to 1,320 (1,650) pence - 'buy'

----------

Berenberg raises Tharisa price target to 260 (240) pence - 'buy'

----------

Deutsche Bank cuts Ferguson price target to 9,630 (9,960) pence - 'hold'

----------

Barclays raises AIB price target to 3.80 (3.40) EUR - 'equal weight'

----------

Jefferies cuts Watkin Jones to 'hold' (buy) - price target 111 (225) pence

----------

Jefferies cuts Kingspan to 'underperform' (hold) - price target 45.90 (63.60) EUR

----------

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
Today 10:27

AstraZeneca trials yield positive results for immunocompromised patients

(Alliance News) - AstraZeneca PLC on Thursday said results from recent trials revealed a significant reduction in cases of Covid-19.

Read more
12 May 2024 13:25

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

PARIS, May 12 (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose France' business summit.

Read more
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.